Check-Cap Ltd. (CHEK)

USD 0.6

(-0.84%)

Gross Profit Summary of Check-Cap Ltd.

  • Check-Cap Ltd.'s latest annual gross profit in 2023 was -212 Thousand USD , up 47.65% from previous year.
  • Check-Cap Ltd.'s latest quarterly gross profit in 2023 FY was -212 Thousand USD , up 47.65% from previous quarter.
  • Check-Cap Ltd. reported a annual gross profit of -405 Thousand USD in annual gross profit 2022, down -97.56% from previous year.
  • Check-Cap Ltd. reported a annual gross profit of -205 Thousand USD in annual gross profit 2021, down -38.51% from previous year.
  • Check-Cap Ltd. reported a quarterly gross profit of -95 Thousand USD for 2023 Q2, down 0.0% from previous quarter.
  • Check-Cap Ltd. reported a quarterly gross profit of -212 Thousand USD for 2023 FY, up 47.65% from previous quarter.

Annual Gross Profit Chart of Check-Cap Ltd. (2023 - 2012)

Historical Annual Gross Profit of Check-Cap Ltd. (2023 - 2012)

Year Gross Profit Gross Profit Growth
2023 -212 Thousand USD 47.65%
2022 -405 Thousand USD -97.56%
2021 -205 Thousand USD -38.51%
2020 -148 Thousand USD -28.7%
2019 -115 Thousand USD 22.3%
2018 -148 Thousand USD 5.73%
2017 -157 Thousand USD -237.72%
2016 114 Thousand USD 40.74%
2015 81 Thousand USD 110.28%
2014 -788 Thousand USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Gross Profit Comparison of Check-Cap Ltd.

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD 102.216%
Prenetics Global Limited 8.82 Million USD 102.401%
Star Equity Holdings, Inc. 11.92 Million USD 101.778%
CareDx, Inc 178.32 Million USD 100.119%
Exact Sciences Corporation 1.84 Billion USD 100.011%
Exagen Inc. 29.45 Million USD 100.72%
Inotiv, Inc. 165.44 Million USD 100.128%
Guardant Health, Inc. 336.89 Million USD 100.063%
Biodesix, Inc. 36.07 Million USD 100.588%
BioNexus Gene Lab Corp. 1.32 Million USD 115.946%
Precipio, Inc. 6.01 Million USD 103.523%
iSpecimen Inc. 5.1 Million USD 104.15%
Natera, Inc. 492.74 Million USD 100.043%
Aspira Women's Health Inc. 5.26 Million USD 104.029%
Standard BioTools Inc. 50.45 Million USD 100.42%
23andMe Holding Co. 99.37 Million USD 100.213%
Castle Biosciences, Inc. 174.8 Million USD 100.121%
Personalis, Inc. 18.2 Million USD 101.164%
Aclaris Therapeutics, Inc. 13.16 Million USD 101.61%
Applied DNA Sciences, Inc. 5.53 Million USD 103.831%
OpGen, Inc. -90.69 Thousand USD -133.753%
T2 Biosystems, Inc. -8.17 Million USD 97.405%
Myriad Genetics, Inc. 476.4 Million USD 100.045%
ICON Public Limited Company 1.81 Billion USD 100.012%
NeoGenomics, Inc. 244.6 Million USD 100.087%
Star Equity Holdings, Inc. 11.92 Million USD 101.778%
IDEXX Laboratories, Inc. 2.18 Billion USD 100.01%
RadNet, Inc. 93 Million USD 100.228%
MDxHealth SA 43.92 Million USD 100.483%
Psychemedics Corporation 8.41 Million USD 102.52%
Illumina, Inc. 2.74 Billion USD 100.008%
Twist Bioscience Corporation 133.34 Million USD 100.159%
DarioHealth Corp. 5.98 Million USD 103.543%
Fulgent Genetics, Inc. 104.45 Million USD 100.203%
Sera Prognostics, Inc. 96 Thousand USD 320.833%
ENDRA Life Sciences Inc. -275.45 Thousand USD 23.035%
OPKO Health, Inc. 318.12 Million USD 100.067%
Medpace Holdings, Inc. 524.5 Million USD 100.04%
Neogen Corporation 463.9 Million USD 100.046%
Intelligent Bio Solutions Inc. 1.42 Million USD 114.871%
Prenetics Global Limited 8.82 Million USD 102.401%
Mainz Biomed B.V. 509.65 Thousand USD 141.596%
bioAffinity Technologies, Inc. 791.61 Thousand USD 126.781%
Trinity Biotech plc 19.45 Million USD 101.09%
Neuronetics, Inc. 51.7 Million USD 100.41%
Sotera Health Company 577.15 Million USD 100.037%
bioAffinity Technologies, Inc. 791.61 Thousand USD 126.781%